Curious how the FDA might spend its PDUFA fees? A new five-year plan shows that FDA will plow the money into post-marketing safety to meet its commitments under the new law passed last fall. The agency would spend the to boost [1] the number of employees looking at new scientific approaches to drug safety, improving adverse event detection and prevention programs, and cutting back on medication errors. Plus, it would invest millions in epidemiology "best practices" and data acquisition. Want more detail? Check out the plan itself on the FDA website.

- see the plan [2]
- check out the story [3] at FDA News

Related Articles:
FDA aims to hire 1,300 by October [4]
FDA: Drugmakers responsible for safety [5]
House passes PDUFA: bill heads to Senate [6]
Panel: Give FDA power to recall [7]